Featured Publications
What Role Should Psychiatrists Have in Responding to the Opioid Epidemic?
Muvvala SB, Edens EL, Petrakis IL. What Role Should Psychiatrists Have in Responding to the Opioid Epidemic? JAMA Psychiatry 2019, 76: 107-108. PMID: 30484813, DOI: 10.1001/jamapsychiatry.2018.3123.Peer-Reviewed Original Research
2023
Increasing buprenorphine access for patients with chronic pain: a quality improvement initiative
Wesolowicz D, Spelman J, Edmond S, Schwartz A, Kravetz J, Edens E, Becker W. Increasing buprenorphine access for patients with chronic pain: a quality improvement initiative. Pain Medicine 2023, 25: 226-230. PMID: 37847654, DOI: 10.1093/pm/pnad140.Peer-Reviewed Original ResearchQuality improvement initiativesSpecialty pain clinicPrimary care providersPrimary careChronic painPain clinicCare providersImprovement initiativesVeterans Health Administration healthcare systemFull agonist opioidsPrimary care clinicsNumber of patientsEligible patientsBuprenorphine prescribingCare clinicsPain careProvider comfortStandard operating proceduresBuprenorphine accessBuprenorphinePainPrescribingPatientsEducational sessionsClinic
2021
An Interdisciplinary Approach to Metastatic Pancreatic Cancer and Comorbid Opioid Use Disorder Treatment Within a VA Health Care System.
Ruskin A, Falker CG, Edens EL, Bauer MR. An Interdisciplinary Approach to Metastatic Pancreatic Cancer and Comorbid Opioid Use Disorder Treatment Within a VA Health Care System. Federal Practitioner 2021, 38: s66-s71. PMID: 34733097, PMCID: PMC8560123, DOI: 10.12788/fp.0160.Peer-Reviewed Original ResearchPancreatic cancerOpioid use disorder treatmentVA health care systemActive substance use disorderAdvanced pancreatic cancerMetastatic pancreatic cancerUse disorder treatmentSubstance use disordersHealth care systemUse disordersDisorder treatmentCancer treatmentCare systemMultidisciplinary approachCancerTreatmentPatients
2018
Co-occurring Substance and Mental Health Disorders
Jorandby-Quinones L, Edens E, Rosenheck R. Co-occurring Substance and Mental Health Disorders. 2018, 307-333. DOI: 10.1007/978-1-4939-7438-2_20.ChaptersDual diagnosisMental health care deliveryHigh treatment burdenMore medical conditionsMental health care systemMental health disordersSubstance use disordersCo-occurring substanceEvolution of treatmentHealthcare delivery approachHealth care deliveryHealth care systemTreatment burdenMedical conditionsUse disordersHealth disordersMedical carePatientsCare deliveryPsychosocial conditionsIndividual diseasesCare systemDiagnosisTreatmentDisease
2016
Management of patients with issues related to opioid safety, efficacy and/or misuse: a case series from an integrated, interdisciplinary clinic
Becker WC, Merlin JS, Manhapra A, Edens EL. Management of patients with issues related to opioid safety, efficacy and/or misuse: a case series from an integrated, interdisciplinary clinic. Addiction Science & Clinical Practice 2016, 11: 3. PMID: 26818474, PMCID: PMC4730605, DOI: 10.1186/s13722-016-0050-0.Peer-Reviewed Original ResearchConceptsChronic painOpioid safetyInterdisciplinary clinicClinical scenariosCo-occurring chronic painMultimodal pain careManagement of patientsOpioid use disorderTreatment of patientsLack of efficacySimilar clinical scenariosComplex clinical scenariosQuality of careHazardous alcohol useSubstance abuse treatmentOpioid treatmentBuprenorphine/Case seriesPain careMultimodal treatmentClinical equipoisePrimary careUse disordersPainPatients
2011
Treatment With Acamprosate in Patients With Schizophrenia Spectrum Disorders and Comorbid Alcohol Dependence
Ralevski E, O’Brien E, Jane JS, Dwan R, Dean E, Edens E, Arnaout B, Keegan K, Drew S, Petrakis I. Treatment With Acamprosate in Patients With Schizophrenia Spectrum Disorders and Comorbid Alcohol Dependence. Journal Of Dual Diagnosis 2011, 7: 64-73. PMID: 26954912, DOI: 10.1080/15504263.2011.569440.Peer-Reviewed Original ResearchEfficacy of acamprosateAlcohol dependenceSchizophrenia spectrum disordersMedication treatmentComorbid schizophreniaSignificant group x time interactionGroup x time interactionComorbid alcohol dependenceAlcohol use disorderSymptoms of schizophreniaX time interactionAcamprosate groupComorbid conditionsTreatment trialsAbstinent patientsClinical trialsSpectrum disorderAcamprosateGeneral populationUse disordersPatientsSchizoaffective disorderPositive symptomsSchizophrenic symptomsConsecutive days